This is the first insider transaction for the company in the last 90 days. This compares with the preceding 90-day window of time where there were 11 transactions from 5 insiders which resulted in the net acquisition of 73,428 shares.
This is less than the average level of insider transactions in the 324-company Bio Therapeutic Drugs peer group over the last 90-day period. Within the peer group activity averaged 37.5 transactions per company, with company insiders acquiring on average 15,767 shares.
SEC Story Link http://www.sec.gov/Archives/edgar/data/872589/000114036119016600/xslF345X03/form4.xml
|Q4 Estimate for Vince Holding Lowered but Full Year ...|
|2020, 2021, and Q2 Earnings Estimates for United Nat...|
|LendingTree's 2020 Earnings Estimate Lowered|
|Total's Q4 and 2020, Estimates Raised but 2019 Earni...|
|Team's 2020 Earnings Projection Cut|